The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 634-638

  Mohd Suzairi, Mohd Shafi'i ^a   Tan, Shing Cheng ^a   Ahmad Aizat, Abdul Aziz ^a   Mohd Aminudin, Mustapha ^a   Siti Nurfatimah, Mohd Shahpudin ^a   Andee, Zakaria Dzulkarnaen ^a   Ankathil, Ravindran ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Colorectal cancer; NFKB1; Polymorphism; Predisposition; Risk; Rs28362491; Susceptibility

Indexed keywords

GENOMIC DNA; PROTEIN; PROTEIN NFKB1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

COLORECTAL CANCER; NFKB1; POLYMORPHISM; PREDISPOSITION; RISK; RS28362491; SUSCEPTIBILITY;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; MALAYSIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NF-KAPPA B P50 SUBUNIT; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 84884160529     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.05.007     Document Type: Article

References (32)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] 2010, International Agency for Research on Cancer, Lyon, France, Available from: http://globocan.iarc.fr [accessed March 2013].
2. Ahmed F.E. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006, 24(1):1-101.
3. Heavey P.M., McKenna D., Rowland I.R. Colorectal cancer and the relationship between genes and the environment. Nutr Cancer 2004, 48(2):124-141.
4. Bodmer W.F. Cancer genetics: colorectal cancer as a model. J Hum Genet 2006, 51(5):391-396.
5. Mimori K., Tanaka F., Shibata K., Mori M. Review: single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer. Surg Today 2012, 42(3):215-219.
6. Dong L.M., Potter J.D., White E., Ulrich C.M., Cardon L.R., Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008, 299(20):2423-2436.
7. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4(10):769-780.
8. Karin M., Greten F.R. NF-kappaB linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5(10):749-759.
9. Sun X.F., Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007, 22(12):1387-1398.
10. Oeckinghaus A., Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009, 1(4):a000034.
11. Karban A.S., Okazaki T., Panhuysen C.I., Gallegos T., Potter J.J., Bailey-Wilson J.E., et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004, 13(1):35-45.
12. Song S., Chen D., Lu J., Liao J., Luo Y., Yang Z., et al. NFkB1 and NFkBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a Southern Chinese population. PLoS ONE 2011, 6(6):e21726.
13. Lewander A., Butchi A.K., Gao J., He L.J., Lindblom A., Arbman G., et al. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol 2007, 42(11):1332-1338.
14. Andersen V., Christensen J., Overvad K., Tjønneland A., Vogel U. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010, 10:484.
15. Tak P.P., Firestein G.S. NF-kappaB a key role in inflammatory diseases. J Clin Invest 2001, 107(1):7-11.
16. Naugler W.E., Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008, 18(1):19-26.
17. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6(3):203-208.
18. Wang W., Abbruzzese J.L., Evans D.B., Chiao P.J. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene 1999, 18(32):4554-4563.
19. Lind D.S., Hochwald S.N., Malaty J., Rekkas S., Hebig P., Mishra G., et al. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 2001, 130(2):363-369.
20. Sasaki N., Morisaki T., Hashizume K., Yao T., Tsuneyoshi M., Noshiro H., et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001, 7(12):4136-4142.
21. Biswas D.K., Dai S.C., Cruz A., Weiser B., Graner E., Pardee A.B. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA 2001, 98(18):10386-10391.
22. Tai D.I., Tsai S.L., Chang Y.H., Huang S.N., Chen T.C., Chang K.S., et al. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 2000, 89(11):2274-2281.
23. Chen C.D., Sawyers C.L. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 2002, 22(8):2862-2870.
24. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2(4):301-310.
25. Riemann K., Becker L., Struwe H., Nückel H., Dührsen U., Alakus H., et al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 2006, 16(11):783-788.
26. Tang T., Cui S., Deng X., Gong Z., Jiang G., Wang P., et al. Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol 2010, 29(1):9-12.
27. Lo S.S., Chen J.H., Wu C.W., Lui W.Y. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery 2009, 145(3):280-285.
28. Zhang P., Wei Q., Li X., Wang K., Zeng H., Bu H., et al. A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet 2009, 191(2):73-77.
29. Zhou B., Qie M., Wang Y., Yan L., Zhang Z., Liang A., et al. Relationship between NFKB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol 2010, 21(3):506-511.
30. Zhou B., Rao L., Li Y., Gao L., Wang Y., Chen Y., et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 2009, 275(1):72-76.
31. Elsharkawy A.M., Oakley F., Lin F., Packham G., Mann D.A., Mann J. The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol 2010, 53(3):519-527.
32. Shih V.F., Tsui R., Caldwell A., Hoffmann A. A single NFκB system for both canonical and non-canonical signaling. Cell Res 2011, 21(1):86-102.